David Randolph Collins, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD8-Positive T-Lymphocytes | 4 | 2023 | 4438 | 1.000 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 3 | 2020 | 39 | 0.850 |
Why?
|
| Viremia | 1 | 2021 | 735 | 0.630 |
Why?
|
| HIV Infections | 9 | 2024 | 16678 | 0.590 |
Why?
|
| AIDS Vaccines | 2 | 2020 | 938 | 0.550 |
Why?
|
| HIV-1 | 6 | 2020 | 6934 | 0.480 |
Why?
|
| Capsid Proteins | 1 | 2014 | 479 | 0.370 |
Why?
|
| Immune Evasion | 1 | 2014 | 360 | 0.370 |
Why?
|
| Macrophages | 4 | 2020 | 5655 | 0.350 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2020 | 4379 | 0.350 |
Why?
|
| HLA-B Antigens | 3 | 2024 | 353 | 0.300 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 2023 | 1820 | 0.240 |
Why?
|
| Virion | 2 | 2015 | 433 | 0.220 |
Why?
|
| Germinal Center | 1 | 2023 | 377 | 0.180 |
Why?
|
| Mannose-Binding Lectins | 1 | 2020 | 100 | 0.180 |
Why?
|
| Virus Replication | 3 | 2023 | 2531 | 0.180 |
Why?
|
| Macrolides | 1 | 2020 | 201 | 0.170 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2023 | 880 | 0.170 |
Why?
|
| Adoptive Transfer | 1 | 2020 | 844 | 0.150 |
Why?
|
| Heterozygote | 1 | 2024 | 2790 | 0.150 |
Why?
|
| Lectins, C-Type | 1 | 2020 | 588 | 0.140 |
Why?
|
| Immunization | 1 | 2020 | 1255 | 0.130 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2014 | 127 | 0.120 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2018 | 1368 | 0.120 |
Why?
|
| Gene Products, gag | 1 | 2014 | 337 | 0.120 |
Why?
|
| Immunity, Cellular | 1 | 2020 | 1606 | 0.120 |
Why?
|
| Retroviridae | 1 | 2014 | 914 | 0.100 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2014 | 370 | 0.100 |
Why?
|
| Lymph Nodes | 1 | 2023 | 3465 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 1477 | 0.100 |
Why?
|
| Interferon-alpha | 1 | 2015 | 895 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2020 | 2867 | 0.090 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2019 | 2231 | 0.090 |
Why?
|
| Anti-Retroviral Agents | 1 | 2020 | 1712 | 0.090 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 1970 | 0.090 |
Why?
|
| Recurrence | 1 | 2021 | 8333 | 0.090 |
Why?
|
| RNA, Viral | 1 | 2014 | 2899 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2014 | 3744 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2020 | 1366 | 0.060 |
Why?
|
| Humans | 13 | 2024 | 742088 | 0.050 |
Why?
|
| Peptides | 2 | 2024 | 4392 | 0.050 |
Why?
|
| Alleles | 2 | 2024 | 6931 | 0.050 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2020 | 153 | 0.050 |
Why?
|
| Gene Products, nef | 1 | 2020 | 110 | 0.050 |
Why?
|
| Gene Products, env | 1 | 2020 | 263 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2014 | 3127 | 0.040 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 222 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2019 | 1202 | 0.030 |
Why?
|
| Protein Binding | 2 | 2020 | 9387 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 2524 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2020 | 19223 | 0.030 |
Why?
|
| Middle Aged | 2 | 2024 | 213127 | 0.020 |
Why?
|
| Interferons | 1 | 2014 | 704 | 0.020 |
Why?
|
| Adult | 2 | 2024 | 213712 | 0.020 |
Why?
|
| Proteome | 1 | 2019 | 1790 | 0.020 |
Why?
|
| Male | 2 | 2024 | 349538 | 0.020 |
Why?
|
| Disease Progression | 1 | 2024 | 13256 | 0.020 |
Why?
|
| Female | 2 | 2024 | 379592 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 1860 | 0.020 |
Why?
|
| Animals | 1 | 2014 | 168561 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2014 | 5019 | 0.010 |
Why?
|
| Young Adult | 1 | 2024 | 56350 | 0.010 |
Why?
|
| Mutation | 1 | 2019 | 29717 | 0.010 |
Why?
|
| Aged | 1 | 2024 | 162944 | 0.010 |
Why?
|